Paysign, Inc. Reports Strong Q1 2025 Financial Growth

PaySign Inc Class B ( (PAYS) ) has released its Q1 earnings. Here is a breakdown of the information PaySign Inc Class B presented to its investors.

Paysign, Inc. is a financial services provider specializing in prepaid card programs, patient affordability solutions, and integrated payment processing, primarily serving the healthcare industry. In its first quarter of 2025, Paysign reported a significant increase in total revenues, reaching $18.60 million, a 41% rise compared to the same period in 2024. The company also saw a substantial growth in net income, which rose to $2.59 million from $309 thousand a year ago.

Key financial highlights include a 193.3% increase in Adjusted EBITDA, which reached $4.96 million, and a notable expansion in gross margins by 10.3 percentage points. The company added 14 new patient affordability programs, contributing to a 260.8% increase in pharma patient affordability revenue. However, plasma revenue saw a decline of 9.2% due to industry-wide oversupply issues.

Paysign ended the quarter with $6.85 million in unrestricted cash and no bank debt, having repurchased 100,000 shares of common stock. Despite a decrease in gross dollar load and spend volumes, the company maintained a strong financial position and continued to expand its plasma center count and patient affordability programs.

Looking forward, Paysign’s management remains optimistic about the company’s growth trajectory, particularly with the integration of Gamma Innovation’s capabilities. The company expects continued revenue growth, driven by its patient affordability business, and aims to enhance operational efficiencies to sustain long-term growth in the healthcare sector.